Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer
Clinical trial NCT00408434 · COMPLETED
Trial details
- NCT number
- NCT00408434
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2010-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.